Supriya Lifescience Ltd - 543434 - Business Responsibility Report For The Financial Year 2021-22
In compliance with Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the Business Responsibility Report of the Company for the Financial Year 2021-22. Kindly take the above said information on your records. Supriya Lifescience Ltd - 543434 - Reg. 34 (1) Annual Report.
As required under Regulation 30 and Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Annual Report of the Company for the Financial Year 2021-22 along with the Notice convening the 14th Annual General Meeting ("AGM") scheduled to be held on Friday, September 16, 2022 at 03:00 p.m. (IST) through Video Conferencing/ Other Audio Visual Means in accordance with relevant circulars issued by the Ministry of Corporate Affairs and SEBI. In compliance with the aforesaid circulars, the Annual Report along with the Notice of the AGM has been sent only by electronic mode to those shareholders whose e-mail address is registered with the Company/ Depository. The Annual Report along with the Notice of the AGM for the Financial Year 2021-22 is also available on the website of the Company at www.supriyalifescience.com Kindly take the above said information on your records. Supriya Lifescience Ltd - 543434 - Intimation Of Record Date And Book Closures Date For The Purpose Of Dividend & Annual General Meeting
Pursuant to Section 91 and other applicable provisions, if any of the Companies Act, 2013 and Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books of the Company will remain closed from Saturday September 3, 2022 to Friday, September 16, 2022 (both days inclusive) purpose of Dividend and AGM. The Company has fixed Friday, September 2, 2022 as the 'Record Date' for determining entitlement of Members to final dividend for the financial year ended March 31, 2022, if approved at the AGM. Kindly take the above said information on your records. Supriya Lifescience Ltd - 543434 - Notice Of The 14Th Annual General Meeting
Please find enclosed herewith the Notice convening the 14th Annual General Meeting ("AGM") of the Company scheduled to be held on Friday, September 16, 2022 at 03:00 p.m. (IST) through Video Conferencing/ Other Audio Visual Means in accordance with relevant circulars issued by the Ministry of Corporate Affairs and SEBI. In compliance with the aforesaid circulars, the Annual Report along with the Notice of the AGM has been sent only by electronic mode to those shareholders whose e-mail address is registered with the Company/ Registrar and Transfer Agent of the Company /Depository. The Annual Report along with the Notice of the AGM for the Financial Year 2021-22 is also available on the website of the Company at www.supriyalifescience.com Kindly take the above said information on your records. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in compliance with Ministry of Corporate Affairs Circular dated May 5, 2022, December 14, 2021, January 13, 2021, May 5, 2020, April 13, 2020 and April 8, 2020 respectively, the Company has published Newspaper Advertisements for the attention of the Equity Shareholders of the Company in respect of information regarding the 14th AGM scheduled to be held on Friday, September 16, 2022 at 3:00 p.m. (IST) through Video Conferencing/Other Audio-Visual Means in the following newspapers: i. Financial Express (English Language) ii. Loksatta (Marathi Language) Kindly take the above said information on your records.
Accumulate Supriya Lifescience; target of Rs 410: KR Choksey
KR Choksey recommended accumulate rating on Supriya Lifescience with a target price of Rs 410 in its research report dated August 18, 2022.
Results Earnings Call for Q1FY23 of Supriya Lifescience
Conference Call with Supriya Lifescience Management and Analysts on Q1FY23 Performance and Outlook. Listen to the full earnings transcript. Supriya Lifescience Ltd - 543434 - Audio Recording Of Earnings Call
In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company''s Earnings Call held today (i.e., August 16, 2022) regarding discussion on operational and financial performance for the First Quarter of FY 2022-2023 (Q1) is available on the Company''s website. The recording can be accessed from the link given below: https://supriyalifescience.com/investor-relation/financial/earning-call-recordings/ You are requested to kindly take the same on record. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Newspaper Publication
With reference to the above captioned subject, please find enclosed newspaper advertisement published in Financial Express and Loksatta on Saturday, August 13, 2022, containing extract of Unaudited Financial Results for the quarter ended June 30, 2022. You are requested to kindly take the same on record. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation. You are requested to kindly take the same on record.